About Us
Imagine a groundbreaking way to detect Type 2 Diabetes (T2DM) earlier than the current gold standard Hemoglobin A1c test (1). Early detection provides a critical window to make life adjustments that can slow—or even prevent—the progression of T2DM.
Stapgen’s team of scientists has uncovered a remarkable connection between T2DM and the levels of an enzyme in the intestines called alkaline phosphatase (IAP). This discovery led to the development of a patented, simple diagnostic test—the STAP-Test—that measures IAP levels to identify T2DM risk before traditional blood sugar markers rise.
Now, imagine you’ve been diagnosed with pre-Type 2 Diabetes. You’re seeking ways to reverse your course and avoid full diabetes. Stapgen has pioneered a proprietary IAP supplement designed to restore healthy enzyme levels, empowering individuals to take control of their health and improve outcomes.
At Stapgen, we’re not just imagining a better future—we’re making it a reality.
(1) Hemoglobin A1c test measures the average blood sugar levels and reflects long-term blood sugar control.
Steps to prevention:
Living Well Preventing Diabetes:
Your Trusted Guide to a Healthier Life.
Contrary to popular belief, Type 2 Diabetes is preventable:
Step 1: Detection of IAP Deficiency.
STAP-Test: A patented diagnostic tool (US10781470B2) that identifies Intestinal Alkaline Phosphatase (IAP) deficiency.
Why It Matters: IAP is a critical enzyme that maintains gut microbiome balance and reduces inflammation, both of which are key to preventing T2DM.
The Innovation: The STAP-Test enables detection of IAP deficiency long before blood glucose levels become abnormal, allowing for timely intervention.
Step 2: Early Prediction of T2DM Data-Driven Insight.
Data-Driven Insights: Clinical studies have established IAP deficiency as a strong predictor of T2DM risk.
Impact: By leveraging STAP-Test results, individuals at high risk of developing T2DM can be identified and monitored proactively, paving the way for targeted prevention strategies.
Step 3: Prevention of T2DM Using SGt2d Therapeutic.
SGt2d Therapeutic: A patent-pending treatment (Application #18/296,445) that restores and maintains normal IAP levels.
4.5
Years Experience
120K
Trusted People
22
Project Completed
705+
Positive Response
Diabetes website about us
Welcome to Stapgen, your trusted resource for understanding and managing diabetes. Our mission is to empower individuals and families with accurate, up-to-date information on diabetes care, treatment, and healthy living. Whether you are newly diagnosed as pre-diabetic or looking for ways to better manage your condition, we provide reliable guidance to support your journey.
